From: Radiotherapy for inferior vena cava tumor thrombus in patients with hepatocellular carcinoma
Variable | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Age (< 65 vs. ≥65 years) | 0.709 (0.350–1.434) | 0.338 | ||
Gender (female vs. male) | 0.748 (0.502–1.114) | 0.153 | ||
ECOG performance status (2–3 vs. 0–1) | 1.656 (1.138–2.410) | 0.008 | 1.175 (0.365–3.776) | 0.787 |
Child-Pugh class (B&C vs. A) | 2.123 (1.472–3.062) | 0.000 | 2.411 (1.073–5.414) | 0.033 |
Right atrium invasion (yes vs. no) | 1.330 (0.905–1.952) | 0.146 | ||
Portal vein invasion (yes vs. no) | 1.961 (1.343–2.864) | 0.000 | 1.086 (0.662–1.782) | 0.743 |
Hepatic vein invasion (yes vs. no) | 0.970 (0.662–1.422) | 0.876 | ||
LN metastasis (yes vs. no) | 1.926 (1.232–3.010) | 0.004 | 2.118 (1.171–3.831) | 0.013 |
Lung metastasis (yes vs. no) | 1.509 (1.000–2.276) | 0.050 | 1.751 (1.064–2.883) | 0.028 |
Systemic treatmenta (without vs. with) | 2.430 (1.625–3.634) | 0.000 | 1.346 (0.680–2.667) | 0.394 |
RT dose (EQD10/2, Gy)b (<50 vs. ≥50) | 1.583 (1.100–2.280) | 0.013 | 1.050 (0.669–1.649) | 0.832 |
Objective response of IVCc (no vs. yes) | 2.326 (1.552–3.488) | 0.000 | 2.604 (1.544–4.391) | 0.000 |